Anne Li Cancer rates are increasing, meaning more people than ever are being diagnosed with the disease. And with more people to look after, the NHS is coming under growing strain to meet demand – especially as it strives to meet the priority of diagnosing more cancers earlier. To deliver…...
Blood test could predict skin cancer’s return
Anne Li Cancer Research UK scientists have discovered that testing skin cancer patients’ blood for tumour DNA could help predict the chances of an aggressive cancer returning. Published in the Annals of Oncology, the findings could pave the way to identifying patients who are most at risk of their disease…...
Breast cancer less likely to come back with more intensive chemo
Anne Li Giving chemotherapy in higher average doses reduces the risk of early stage breast cancer coming back. More intense chemotherapy dosing also reduced the risk of patients dying from their breast cancer, compared to less intense dosing. Dose intensity can be increased by shortening the intervals between chemotherapy treatments,…...
Novel compound restores immune response in patients with melanoma
Anne Li A novel compound may restore immune response in patients with melanoma, according to a study presented at the ESMO Immuno Oncology Congress 2017. “Checkpoint inhibitors are a standard of care immunotherapy for metastatic melanoma,” said lead author Dr Sapna Patel, Assistant Professor, Department of Melanoma Medical Oncology, University…...
Including diagnosis related costs, 3-D mammography costs less than digital mammography
Anne Li Although digital breast tomosynthesis (DBT), or 3-D mammography, costs more than a digital mammography (DM) screening, it actually may help rein in cancer screening costs, according to preliminary findings (PD7-05) presented by researchers from the Perelman School of Medicine at the University of Pennsylvania during the 2017 San…...
Go with the flow (or against it)
Anne Li Queen’s University researchers are using magnetic fields to influence a specific type of bacteria to swim against strong currents, opening up the potential of using the microscopic organisms for drug delivery in environments with complex microflows — like the human bloodstream. Led by Carlos Escobedo (Chemical Engineering) and…...
Novel regulation of gene expression in brain tumors identified
Anne Li Study results revealed previously unknown interplay between two key enzymes and a novel understanding of how brain cancer tumors form and spread, according to researchers at The University of Texas MD Anderson Cancer Center. The study, led by Zhimin Lu, M.D., Ph.D., professor of Neuro-Oncology, identified a previously…...
First line combination therapy improves progression-free survival in advanced lung cancer
Anne Li A new combination therapy for the first line treatment of advanced non-squamous non-small-cell lung cancer (NSCLC) improves progression-free survival (PFS), according to results of the phase III IMpower150 trial presented at the ESMO Immuno Oncology Congress 2017. “This is the first phase III trial to report on the…...
